Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Szelenyi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 17, 2013
Flupirtine, a re-discovered drug, revisitedIstvan Szelenyi
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 8, 2011
Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseasesIstvan Szelenyi
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2003
Unconventional therapies in asthmaIstvan Szelenyi, Kay Brune
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Herbal remedies for asthma treatment: between myth and realityIstvan Szelenyi, Kay Brune
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|April 4, 2006
Is asthma research in dead end?Annette Amon, Andreas Pahl, Istvan Szelenyi
Drug News & Perspectives|July 11, 2006
Are there any realistic chances to develop new drugs for asthma?Annette Amon, Andreas Pahl, Istvan Szelenyi
Expert Review of Clinical Immunology|May 19, 2010
Cilomilast, an orally active phosphodiesterase 4 inhibitor for the treatment of COPDWolfgang Baeumer, Istvan Szelenyi, Manfred Kietzmann
British Journal of Pharmacology|April 18, 2002
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapyAndreas Pahl, Meixia Zhang, Hildegard Kuss, et al.
Pulmonary Pharmacology & Therapeutics|April 24, 2002
Modulation of TNF and GM-CSF release from dispersed human nasal polyp cells and human whole blood by inhibitors of different PDE isoenzymes and glucocorticoidsDegenhard Marx, Mahmoud Tassabehji, Sabine Heer, et al.
Pharmacology, Biochemistry, and Behavior|March 10, 2004
New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, EstredoxMariann K Tapfer, Laszlo Sebestyen, Istvan Kurucz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 17, 2013
Flupirtine, a re-discovered drug, revisitedIstvan Szelenyi
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 8, 2011
Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseasesIstvan Szelenyi
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2003
Unconventional therapies in asthmaIstvan Szelenyi, Kay Brune
Drugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Herbal remedies for asthma treatment: between myth and realityIstvan Szelenyi, Kay Brune
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|April 4, 2006
Is asthma research in dead end?Annette Amon, Andreas Pahl, Istvan Szelenyi
Drug News & Perspectives|July 11, 2006
Are there any realistic chances to develop new drugs for asthma?Annette Amon, Andreas Pahl, Istvan Szelenyi
Expert Review of Clinical Immunology|May 19, 2010
Cilomilast, an orally active phosphodiesterase 4 inhibitor for the treatment of COPDWolfgang Baeumer, Istvan Szelenyi, Manfred Kietzmann
British Journal of Pharmacology|April 18, 2002
Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapyAndreas Pahl, Meixia Zhang, Hildegard Kuss, et al.
Pulmonary Pharmacology & Therapeutics|April 24, 2002
Modulation of TNF and GM-CSF release from dispersed human nasal polyp cells and human whole blood by inhibitors of different PDE isoenzymes and glucocorticoidsDegenhard Marx, Mahmoud Tassabehji, Sabine Heer, et al.
Pharmacology, Biochemistry, and Behavior|March 10, 2004
New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, EstredoxMariann K Tapfer, Laszlo Sebestyen, Istvan Kurucz, et al.
Pageof 2